Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
Reblozyl is a standard of care for the first-line treatment of anemia without previous erythropoiesis stimulating agent use
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
Lonza to develop spray-dried formulations for an intranasally-delivered biologic for Iconovo at its Center of Excellence for bioavailability enhancement and inhaled delivery in Bend (US)
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Subscribe To Our Newsletter & Stay Updated
